Literature DB >> 14194393

PATHOGENESIS OF INFLAMMATION. I. THE PRODUCTION OF AN INFLAMMATORY SUBSTANCE FROM RABBIT GRANULOCYTES IN VITRO AND ITS RELATIONSHIP TO LEUCOCYTE PYROGEN.

J M MOSES, R H EBERT, R C GRAHAM, K L BRINE.   

Abstract

Material obtained from the in vitro incubation of granulocytes from saline-induced peritoneal exudates of rabbits has been shown to produce inflammation and fever in rabbits. The supernatant material from cells incubated in saline has been termed granulocytic substance (GS) and is heat-labile. Its production is temperature dependent, occurring at 37 degrees C but not at 4 degrees C, requires viable cells, and is inhibited by potassium ions. A similar material is liberated when cells are incubated in a more physiologic medium. Freezing and thawing of granulocytes does not release GS and the active principle cannot be obtained from the incubation of lymphocytes. GS produces a delayed inflammatory response as measured by leucocyte sticking and emigration in the rabbit ear chamber and the leakage of protein-conjugated dye at the site of intradermal injection. The former response can be accurately quantitated by calculation of the inflammatory index from reactions observed in the ear chamber. The inflammatory reaction and the properties of GS distinguish it from a variety of previously described mediators of inflammation, but GS appears to be identical with leucocytic pyrogen. The possible role of GS in delayed and protracted inflammation and its relationship to the pathogenesis of fever are discussed.

Entities:  

Keywords:  CYTOPLASMIC GRANULES; EXPERIMENTAL LAB STUDY; INFLAMMATION; LEUKOCYTES; PYROGENS; RABBITS

Mesh:

Substances:

Year:  1964        PMID: 14194393      PMCID: PMC2137718          DOI: 10.1084/jem.120.1.57

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

1.  Molecular mechanisms involved in the release of pyrogen from polymorphonuclear leucocytes.

Authors:  R D BERLIN; W B WOOD
Journal:  Trans Assoc Am Physicians       Date:  1962

2.  Vascular permeability changes in inflammation: the role of endogenous permeability factors in mild thermal injury.

Authors:  D L WILHELM; B MASON
Journal:  Br J Exp Pathol       Date:  1960-10

3.  Substances which affect capillary permeability.

Authors:  W G SPECTOR
Journal:  Pharmacol Rev       Date:  1958-12       Impact factor: 25.468

4.  Hagerman factor and capillary permeability.

Authors:  J MARGOLIS
Journal:  Aust J Exp Biol Med Sci       Date:  1959-06

5.  Determination of cell viability.

Authors:  J H HANKS; J H WALLACE
Journal:  Proc Soc Exp Biol Med       Date:  1958-05

6.  TOLERANCE TO BACTERIAL PYROGENS : I. FACTORS INFLUENCING ITS DEVELOPMENT.

Authors:  P B Beeson
Journal:  J Exp Med       Date:  1947-06-30       Impact factor: 14.307

7.  Studies on the pathogenesis of fever. XI. Quantitative features of the febrile response to leucocytic pyrogen.

Authors:  D L BORNSTEIN; C BREDENBERG; W B WOOD
Journal:  J Exp Med       Date:  1963-03-01       Impact factor: 14.307

8.  Studies on the pathogenesis of fever. II. Characterization of fever-producing substances from polymorphonuclear leukocytes and from the fluid of sterile exudates.

Authors:  I L BENNETT; P B BEESON
Journal:  J Exp Med       Date:  1953-11       Impact factor: 14.307

9.  Studies on the pathogenesis of fever. X. The effect of certain enzyme inhibitors on the production and activity of leucocvtic pvrogen.

Authors:  H K KAISER; W B WOOD
Journal:  J Exp Med       Date:  1962-01-01       Impact factor: 14.307

10.  The role of polymorphonuclear leukocytes in the initiation and cessation of the Arthus vasculitis.

Authors:  C G COCHRANE; W O WEIGLE; F J DIXON
Journal:  J Exp Med       Date:  1959-09-01       Impact factor: 14.307

View more
  10 in total

1.  Modulation of the inflammatory response by products released from human polymorphonuclear leukocytes during phagocytosis : Generation and inactivation of the chemotactic factor C5a.

Authors:  D G Wright; J I Gallin
Journal:  Inflammation       Date:  1975-03       Impact factor: 4.092

2.  Studies on the mechanism of endogenous pyrogen production. II. Role of cell products in the regulation of pyrogen release from blood leukocytes.

Authors:  P Bodel
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

3.  [Study on the effect of Trasylol. I. Effect of Trasylol on migration and degranulation of neutrophilic granulocytes, comparison with prednisolone].

Authors:  E Kifor; E Werle
Journal:  Blut       Date:  1973-01

4.  Synovial inflammatory response to bacterial endotoxin.

Authors:  J W Hollingsworth; E Atkins
Journal:  Yale J Biol Med       Date:  1965-12

5.  PATHOGENESIS OF INFLAMMATION. II. IN VIVO OBSERVATIONS OF THE INFLAMMATORY EFFECTS OF ACTIVATED HAGEMAN FACTOR AND BRADYKININ.

Authors:  R C GRAHAM; R H EBERT; O D RATNOFF; J M MOSES
Journal:  J Exp Med       Date:  1965-05-01       Impact factor: 14.307

6.  Polymorphonuclear leukocytes in immunologic reactions. The destruction of vascular basement membrane in vivo and in vitro.

Authors:  C G Cochrane; B S Aikin
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

7.  The acute inflammatory reaction in the rabbit ear chamber with particular reference to the phenomenon of leukocytic migration.

Authors:  W J Cliff
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

8.  Mediators of inflammation in leukocyte lysosomes. VI. Partial purification and characterization of a mast cell-rupturing component.

Authors:  W Seegers; A Janoff
Journal:  J Exp Med       Date:  1966-11-01       Impact factor: 14.307

9.  Mediators of inflammation in leukocyte lysosomes. II. Mechanism of action of lysosomal cationic protein upon vascular permeability in the rat.

Authors:  A Janoff; S Schaefer; J Scherer; M A Bean
Journal:  J Exp Med       Date:  1965-11-01       Impact factor: 14.307

10.  Crystal-induced inflammation in canine joints. I. An experimental model with quantification of the host response.

Authors:  D J McCarty; P Phelps; J Pyenson
Journal:  J Exp Med       Date:  1966-07-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.